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The End of NAFTA and
a Future for Companies
in the Medical Device
Industry
MELISSA GUIMOND and JENNIFER KROUSE,
with KYLE BEAUREGARD

I

n 1994, the North American Free Trade Agreement
(NAFTA) created one of the world’s largest free
trade zones and established the foundation for
economic growth and increased prosperity for
Canada, the United States, and Mexico. This essay sets
out to examine how proposed changes to NAFTA could
affect the Medical Device Industry.1 In recent weeks,
U.S. President Donald Trump has threatened to scrap
NAFTA or limit the number of economic sectors that
“free trade” with Canada and Mexico could encompass.
Were this to happen, the medical device industry
could be impacted in both positive and negative ways.
These possible changes create positive impacts for both
Canada and Mexico. Most of the possibly negative
changes directly impact the United States. Our research
analyzes external environmental factors and the industry
as a whole. We look at how the proposed changes
could affect three major companies operating in the
NAFTA region: GE Healthcare, Johnson & Johnson,

Editors’ note. This essay was written in early Spring 2018, months
before the October 2018 conclusion of negotiations resulting in
the United States-Mexico-Canada Trade Agreement (USMCA), the
successor to the North American Free Trade Agreement (NAFTA).
This scholarship provides scholarly insight into the subject that was
available at that moment.
1
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and Medtronic. Through our research, we are able to
generate potential strategies for each of these companies
should the possible changes to NAFTA occur.
While studying the impact of the potential
changes of NAFTA in regard to the Medical Device
Industry, we first need to learn about how the industry
is currently doing and how potential changes proposed
could affect the industry. Our research of the Medical
Device Industry uses a strategic audit approach to
analyze and make recommendations to the top three
companies in the NAFTA region. Were NAFTA to
be scrapped or severely limited, there are a number of
likely impacts on the Medical Device Industry in the
United States. First, Mexico and Canada could retaliate
by imposing restrictions on United States products
that currently have favorable trade terms and high sales
volume. Second, there is the potential for a lower trade
deficit between Mexico and Canada. Third, scrapping
NAFTA might bring about an end to the Value-added
Tax (VAT). The VAT is a type of general consumption
tax that is added incrementally throughout each stage
of production or distribution. This would increase
profit margins for many companies, including those in
medical device production. Lastly, there could be more
complications involved when American-owned factories
stationed in Mexico are moved back to the United States
(Varney, 2017).
Context
Our research includes an assessment of the industry as a
whole within the NAFTA countries, its top sectors, top
trends, and the current performance of GE Healthcare,
Johnson & Johnson and Medtronic. We also use
Porter’s Five Forces, a tool to analyze the competition
of businesses, to assess the Medical Device Industry. It
BRIDGEWATER STATE UNIVERSITY

Figure 1: Basic Facts about Healthcare in NAFTA’s Three Countries
Canada

Mexico

United States

Population

35,099,836

121,736,809

321,368,864

Total Healthcare
Spending

$186 Billion

$82 Billion

$3 Trillion

Healthcare expenditures
total (% of GDP)

10.4%

6.3%

17.1%

Healthcare expenditures
per capita

$5,292 USD

$677 USD

$9,403 USD

Expenditures on
healthcare

Gov’t 71%,
Private 29%

Gov’t 52%, Private 48%

Gov’t 48%,
Private 52%

Size of medical device
market

$6.2 Billion
USD

$5 Billion USD

$147.7 Billion
USD

is a five-force model that determines the competitive
intensity or attractiveness of a company in regard to
its profitability. Figure 1 details some basic facts about
the medical device industry within Canada, Mexico
and the United States. The US dollar is very strong
and constitutes one of the reasons why the medical
device market is on the rise. However, the strong dollar
creates challenges for American device manufacturers
exporting to markets with weaker currencies (Corpart,
2018). Comparing the NAFTA countries gives a deeper
understanding of how each country values healthcare
and the medical device industry.
The Frost & Sullivan website provides a complete
2017 snapshot of the Medical Device Industry.
According to it, the top five sectors of 2017 were:
structural heart, robotics and robot assistance, neurodevices, integrated patient monitoring devices, and
diabetes care. Some of the top technology trends relate
BRIDGEWATER STATE UNIVERSITY

directly to the top sectors, such as the revolution of
diabetes care, surgical robots, and devices that connect
cars and trucks with health sensors. Health sensors
placed on the steering wheels of cars can detect heart
attacks, seizures and other health conditions that could
happen while driving (though this device is still in the
early development stage). With innovation in medical
devices, though, there are always some unexpected issues
that occur. In 2017, some of the concerns raised by
innovation in the medical device industry included those
concerning a restrictive regulatory environment, the
speed of technology, the ability to raise capital to fund
innovations and the changes in customer behavior and
demands. The medical industry is constantly changing
and it is extremely difficult to make sure that products
and devices are reliable. In 2017, there was also a
transformation in the medical device industry ecosystem.
Companies in this sector developed a connected
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ecosystem of sensors and devices that are readily available
to individuals and that serve the functions of identifying,
capturing and measuring health data, stratifying risks,
informing patients of conditions, and helping them and
their physicians to make decisions and take action. These
sensors and devices can be placed on an individual’s
body, in their homes, in community centers, in clinics
and, of course, in hospitals (Frost & Sullivan, 2017).
These sensors are extremely important for innovation
for consumers, such as those with diabetes, who use
them multiple times a day to check blood sugar levels.
The medical device industry is constantly changing
and evolving with new technologies. These changes can
be seen in the current performances of the companies
Medtronic, Johnson & Johnson, and GE Healthcare.
Medtronic
Medtronic is a Global Healthcare and Medical
Device company located in Mansfield, Massachusetts.
Medtronic’s mission statement claims that its first
priority is “to contribute to human welfare by
application of biomedical engineering in the research,
design, manufacture, and sale of instruments or
appliances that alleviate pain, restore health, and extend
life” (Medtronic). Medtronic is growing innovation in
the area of biomedical engineering. In 2017, it invested
more than $2 Billion in research and development,
which represented 7.4% of the company’s net sales that
year. Medtronic also launched labs to bring about new
initiatives to deliver financially sustainable businesses
that expand access and reduce health inequality in
emerging countries (Vivanco, 2017). Medtronic was
a very charitable company in 2017. It donated more
than $101 million to charitable causes in corporate cash
contributions given through the Medtronic Foundation,
in product donations and through employee
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volunteering. The four main product and service
focuses of Medtronic are cardiac and vascular afflictions,
restorative therapies, diabetes, and minimally invasive
therapies.
Johnson & Johnson
Johnson & Johnson is the world’s largest independent
biotech company with a market cap of $343.8 Billion.
A manufacturer of medical devices, pharmaceutical
and consumer packaged goods, it is an American
multinational company that was founded in 1886, with
its headquarters in New Brunswick, New Jersey. In the
third quarter of 2017, Johnson & Johnson’s revenue in
its medical device section was a little more than $19,650
Million. In Johnson & Johnson’s medical device section,
the main products they focus on involve general surgery,
energy science, endocutters, biosurgery, infection
prevention and wound closure. Medical device sales
account for 35% of the company’s value. As a company
that has been around for more than 100 years, Johnson
& Johnson has been and will continue to be a leader of
innovation in the medical field. By 2024, the company’s
forecasting predicts that its revenue will be around
$29 Billion. (Johnson & Johnson - Medical Device).
Johnson & Johnson’s future growth concerns include
changing healthcare needs for an aging population,
changing dynamics in the women’s health market, price
regulation, and developing minimally invasive surgery
procedures to reduce infections. Johnson & Johnson
continues to be the world’s leader of innovation among
biotech companies.
GE Healthcare
GE Healthcare is a sector of GE Capital, whose parent
company is General Electric (GE). GE Healthcare offers
transformational medical technologies and services that
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are shaping a new age of patient care (GE Healthcare).
In the third quarter of 2017, GE Healthcare had revenue
of $4.724 Million, with the medical device segment
recording a profit of $820 Million. The operation
profit of the third quarter of 2017 was 17.4%. GE
Healthcare’s main product categories include accessories
and supplies, the GE Health Cloud, bone and metabolic
health, advanced visualization, computed tomography,
clinical consumables, applied intelligence and anesthesia
delivery. The GE Health Cloud is “designed to be a
scalable, secure, connected and interoperable platform,
delivering the largest application ecosystem for the
healthcare industry” (GE Health Cloud). It is capable
of being connected to more than 500,000 GE medical
imaging machines and more than 1.5 million imaging
machines worldwide. GE Healthcare is making strides
in cloud technology to make the healthcare and medical
world more interconnected.
Porter’s Five Forces
The health of the medical device industry can be gauged
using Porter’s Five Forces, a common methodology
that guides analysis of an industry and the competitors
within it. Porter’s Five Forces are the threat of new
entrants, rivalry among existing firms, the availability
of substitutes, bargaining power among buyers, and
bargaining power among suppliers. Under the first
force, threat of new entrants, we find that it is extremely
difficult for new companies to enter this industry due
to high barriers from strict government regulations.
The industry is also dominated by a few large and top
companies who have strong brand images and long-term
reputations. Barriers to entry include strict regulations
by the U.S. Food and Drug Administration (FDA),
such as approvals, requirements, and registrations, as
well as copyrights and patents. One scholar explains
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the barriers of entry: “There are strict medical device
regulations for product approval by the FDA, which
include establishment registration, medical device listing,
PMA (501) K or premarket approval, investigational
device exemption (IDE) for clinical studies, quality
system regulation, labeling requirements and medical
device reporting (MDR). Couple this with the need for
copyrights and patents and the barrier rises even higher
to enter this industry” (UKEssays, 2017).
In regard to the second force, rivalry amongst
existing firms, there are eight major competitors in this
industry. They are Medtronic, Abbott Laboratories,
Johnson & Johnson, GE Healthcare, Tyco International,
Boston Scientific, Welch Allyn, and Siemens. The
medical device industry is rapidly growing and
constantly changing as a result of new innovations in
healthcare and technology. Products in this industry
are typically items found in hospitals, doctors’ offices,
emergency rooms, and other healthcare facilities. These
include items such as X-Ray machines, MRI machines,
beds, monitors, cardiac devices such as pacemakers,
internal cameras, IV bags, and more. These products also
have high fixed costs associated with them. The third
force is substitute products. There are no substitutes
for these products as they are very specific and cannot
conceivably be replaced. The threat of new substitutes, as
a result, is very low.
The fourth and fifth forces are the bargaining
power of buyers and suppliers, respectively. First,
buyers: quite simply, they do not have the ability to
force down prices. Hospitals and doctors’ offices may
be able to get deals or discounts when making bulk/
large or frequent purchases. Alternative suppliers exist
in competitors outside of the United States in Mexico
and Canada. The importance of these products to the
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buyers is evident: these medical devices save and improve
lives. The bargaining power of suppliers is different; they
can affect the industry with their ability to raise prices.
They can also contribute to making healthcare more
expensive. As stated before, the industry is dominated by
a few companies. Of the eight competitors, the top ones
are GE Healthcare, Johnson & Johnson, Medtronic,
Siemens, and Boston Scientific. Their products have
unique characteristics and are unique themselves.
Some examples of these products are artificial joints
and limbs, stents, orthopedic appliances, surgical
dressings, disposable surgical drapes, hydrotherapy
appliances, surgical kits, rubber medical and surgical
gloves, wheelchairs, anesthesia apparatus, orthopedic
instruments, optical diagnostic apparatus, blood
transfusion devices, syringes, hypodermic needles, and
catheters.
Methodology
Data on how these companies and products might
fare with the end of NAFTA can be organized into
two tables. The first of these is our External Factors
Analysis Summary (EFAS) table. The second table is our
Industry Matrix Analysis. These two tables are crucial
for planning strategies for the three companies we
focus on here: GE Healthcare, Johnson & Johnson and
Medtronic. By utilization of these tables, we can come to
some useful conclusions.
The External Factors Analysis table acts as a
means to track the external factors within an industry.
Prospective changes to NAFTA pose many possible risks
and opportunities for the healthcare industry. The EFAS
table helps clarify these opportunities and threats. Our
research relied on news of the current renegotiations
of NAFTA through news sites and online newspapers
(Harwood, 2017). During this research, it was difficult
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to indicate which possible outcomes could occur because
the negotiations changed pace so quickly and often
(Heath). The EFAS table lists the opportunities and
threats that came with each possible change, and how it
would affect the healthcare and medical device industry
as a whole.
Opportunities refer to the advantages that would
come with specific changes within NAFTA. Here, we
found five important advantages that would directly
impact the healthcare and medical device industry.
Opportunities included lowering the trade deficit
between the US and Mexico and getting rid of the VAT
(Harwood, 2017). Threats act as negative effects that
would hurt the current environment of the healthcare
and medical device industry. Here, we found five
threats, including the end of the Maquiladora program
and the end of resolution panels (Harwood, 2017).
These two direct elements could affect the medical
device industry, causing devices sold outside the United
States to be much more expensive. Given that a large
amount of manufacturing for medical devices is done
in Mexico, these two threats would increase the cost of
manufacturing these products and in turn cause them to
be more expensive for leading healthcare companies.
The second table is the industry matrix table, which.
allows us to organize our findings but also to narrow
down specifics to individual companies within the
United States, namely Medtronic, Johnson & Johnson,
and GE Healthcare. The industry matrix lists the
key success factors needed in order for each of these
companies to achieve success in the healthcare industry.
However, each company takes these success factors and
prioritizes them differently. By using the matrix table
we are able to show how GE Healthcare, Johnson &
Johnson, and Medtronic rank each of these success
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Figure 2: External Factors Analysis
External Factors
Opportunities:
Lower trade deficit between US
and Mexico
Get rid of VAT Tax
Eliminate unfair subsidies
Opportunity to impose tariffs
without permission to congress
Mexico develops internal
healthcare
Threats:

Weights

Rates

Comments

0.05
0.05
0.1

4
3
5

0.05

2

Lowers deficit with Mexico
Gets rid of added tax
Eliminates extra subsidies for healthcare
Allows tariffs to be added without the
approval of Congress

0.2

1.5

Mexico to develops their own healthcare

End of Maquiladora program

0.05

1

Update rule of origin

0.1

3

End of resolution panel
Medical devices from Mexico
more expensive
Potential loss of jobs/work
Total:

0.1

2

0.25
0.05
1.00

3
2.5

Ends the permit that allows Mexico to
import duty free
Ends the advice and discussion between
FDA and medical device sponsors
Medical devices from Mexico would
become more expensive

Figure 3: Industry Matrix Table

Key Success Factors
Innovation
FDA Approval
Product Development
Reliable Products
Top Service Maintenance
Sales and Marketing
Effectiveness
Product Lifecycle
Management
Reputation
Total:
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Johnson &
Medtronic
Johnson
GE Healthcare
Weighted
Weighted
Weighted
Weight
Score
Rating
Score
Rating
Score
Rating
0.2
1
5
0.8
4
1
5
0.16
0.8
5
0.8
5
0.8
5
0.1
0.4
4
0.3
3
0.5
5
0.15
0.6
4
0.6
4
0.6
4
0.12
0.36
3
0.6
5
0.48
4
0.08

0.4

5

0.24

3

0.32

4

0.13
0.06
1

0.52
0.3

4
5

0.52
0.3

4
5

0.52
0.18

4
3
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factors. This allows an overview of each company and
illustrates the main focuses of each leading healthcare
company. For example, by looking at the first key success
factor it, is clear that Medtronic and GE Healthcare list
innovation higher than Johnson & Johnson does (GE
Healthcare). At the same time, Johnson & Johnson
ranks service maintenance higher than both Medtronic
and GE Healthcare (Johnson & Johnson). This shows
that each company has different focuses and relies on
different key success factors in order to achieve success.
Findings
Based upon the information presented in the external
factor analysis summary and industry matrix analysis, we
can devise strategies for the three companies mentioned
above, both generally and in relation to possible
changes in NAFTA. For GE Healthcare, capitalizing
on innovation is paramount in importance given the
company’s goals noted in the industry matrix. It ranked
innovation as one of its top success factors and therefore
would be focusing on it in the future (GE Healthcare).
However, due to possible changes in NAFTA, GE’s focus
on innovation may prove costly. Mexico manufactures
a large amount of medical devices for these three
companies and if any of the threats listed in the EFAS
table occur, innovative technology will not be cheap. In
light of this, making operations more efficient through
automation will be useful should the outsourcing of
manufacturing result in increased costs. Overall, GE
Healthcare should continue to pursue innovation in
medical devices, especially in image archiving and cloud
visualization tools. Outsourcing and operation of devices
could become more expensive for factories in Mexico,
and therefore the company should work on ways to
make the operation process more efficient by using
automated robotics.
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In contrast, Medtronic should continue to
focus its efforts on charity in order to improve the
company’s reputation (Medtronic, 2016). By increasing
its focus on charity events and building a better
reputation, consumers will be more likely to trust
and use Medtronic healthcare and services. This type
of company strategy will bring more popular favor
toward it and set it apart from its competitors. Like GE
Healthcare, innovation is also important to Medtronic
and, because of that, automation is also a key factor
in Medtronic’s future success. Building the company’s
reputation will also cultivate more trust from consumers.
This will in the long run build clientele and give the
company a competitive edge. Finally, Medtronic should
also focus on automated manufacturing and increase
research in its diabetes group, since that is its lowest
profit group within the company. These key goals will
allow Medtronic to continue to flourish, even after the
NAFTA negotiations are complete.
Lastly, Johnson & Johnson should focus on
its work in the field of minimally invasive surgery (or
MIS) procedures (Johnson & Johnson). Evidence from
Johnson & Johnson shows that innovation within the
medical device field is not as important to the company’s
focus as it is to GE Healthcare and Medtronic. Instead,
Johnson & Johnson shows more interest in alternate
forms of innovation, including those that aim to reduce
infection rates. Emphasis on these procedures will set
the company apart from its competitors. Due to possible
changes from the NAFTA negotiations related to
manufacturing, Johnson & Johnson’s focus on innovative
procedures minimizes the need for reconfiguring its
business model. These require little need for outsourcing
manufacturing which may become more expensive as
a result of NAFTA’s renegotiation. MIS procedures are
also expected to be at a higher demand than they are
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currently, which will mean a competitive advantage for
Johnson & Johnson over its leading competitors.
Conclusion
The goal of this research project has been to analyze
the medical device industry and its ties to NAFTA. It
describes the context, business focuses and prospects for
three top companies in the medical device industry: GE
Healthcare, Johnson & Johnson, and Medtronic, and
considers how the scenario of the Trump Administration
pulling the U.S. out of the trade agreement would
affect each one. Our study identifies strategies that
each of the companies could implement if the Trump
administration were to pull the United States out of
the North American Free Trade Agreement. While
Medtronic’s focus on charity is a great way to improve
its reputation, the company should also increase research
in its diabetes group since that is its lowest profit group.
GE Healthcare should continue to increase innovation
in medical devices, especially in image archiving and
cloud visualization tools. Outsourcing and operation of
devices could become more expensive for factories in
Mexico, so the company should work on ways to make
the operation process more efficient with automation
by using robotics. Finally, Johnson & Johnson should
continue to focus its efforts on innovation in minimally
invasive surgeries (MIS) as well as other Healthcare
services. MIS procedures are expected to be at a higher
demand than they are currently, and this strategy
would give Johnson & Johnson an advantage over its
competitors.
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